# Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19

> **NCT05398705** · PHASE2 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 450 (actual)

## Conditions studied

- Asymptomatic COVID-19

## Interventions

- **DRUG:** Cepharanthine
- **DRUG:** Placebo
- **DRUG:** Cepharanthine

## Key facts

- **NCT ID:** NCT05398705
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-31
- **Primary completion:** 2022-08-10
- **Final completion:** 2022-08-10
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2022-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05398705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05398705, "Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05398705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*